scispace - formally typeset
C

Craig M. Jackson

Researcher at Washington University in St. Louis

Publications -  89
Citations -  5572

Craig M. Jackson is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Thrombin & Factor X. The author has an hindex of 39, co-authored 89 publications receiving 5524 citations. Previous affiliations of Craig M. Jackson include National Research Council & University of Queensland.

Papers
More filters
Journal ArticleDOI

Properties of the factor Xa binding site on human platelets.

TL;DR: An antibody that inhibits both human and bovine coagulation Factor V activity blocks both Xa binding to released platelets and the rapid thrombin formation associated with this binding, suggesting that Factor V from platelets is involved in the Xa-platelet interaction.
Journal ArticleDOI

The Conversion of Prothrombin to Thrombin I. CHARACTERIZATION OF THE REACTION PRODUCTS FORMED DURING THE ACTIVATION OF BOVINE PROTHROMBIN

TL;DR: The two activation fragments generated in the presence of activated Factor X alone are indistinguishable from those generated inThe presence ofactivated Factor X, Factor V, and phospholipid by the criteria of disc gel electrophoresis, sodium dodecyl sulfate gel electrospecies, ion exchange chromatography, and amino acid composition.
Journal ArticleDOI

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy

TL;DR: It is proposed that protection of thrombin from inactivation by heparin-antithrombin III by fibrin II monomer can explain the limited efficacy ofheparin in preventing coronary reocclusion in patients treated with tissue plasminogen activator and other fibrinolytic agents.
Book ChapterDOI

Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.

TL;DR: The recognition that both the selectivity of many proteases and their catalytic efficiency depend on interactions with subsite amino acids in the peptide substrate coupled with the availability of amino acid sequences around the cleavage sites in several zymogens of the coagulation and fibrinolytic systems has led to the synthesis and commercial availability of a variety of peptide chromogenic and fluorogenic substrates with much greater selectivity.